Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mitchell Wallin

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Therapeutic Advances in Neurological Disorders|April 19, 2021
Disease-modifying therapy prescription patterns in people with multiple sclerosis by ageYinan Zhang, Amber Salter, Shan Jin, et al.
Neurology|April 14, 2022
The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect CostsBruce Bebo, Inna Cintina, Nicholas LaRocca, et al.
Therapeutic Advances in Neurological Disorders|December 16, 2015
Biomechanical analysis of spasticity treatment in patients with multiple sclerosisMichael Wininger, William Craelius, Jill Settle, et al.
Therapeutic Advances in Neurological Disorders|February 8, 2021
Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trialsYinan Zhang, Natalia Gonzalez Caldito, Afsaneh Shirani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 11, 2020
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third editionClare Walton, Rachel King, Lindsay Rechtman, et al.
Frontiers in Neurology|June 26, 2023
Processing speed and memory test performance are associated with different brain region volumes in Veterans and others with progressive multiple sclerosisRebecca I Spain, Andrea Hildebrand, Carin S Waslo, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Therapeutic Advances in Neurological Disorders|April 19, 2021
Disease-modifying therapy prescription patterns in people with multiple sclerosis by ageYinan Zhang, Amber Salter, Shan Jin, et al.
Neurology|April 14, 2022
The Economic Burden of Multiple Sclerosis in the United States: Estimate of Direct and Indirect CostsBruce Bebo, Inna Cintina, Nicholas LaRocca, et al.
Therapeutic Advances in Neurological Disorders|December 16, 2015
Biomechanical analysis of spasticity treatment in patients with multiple sclerosisMichael Wininger, William Craelius, Jill Settle, et al.
Therapeutic Advances in Neurological Disorders|February 8, 2021
Aging and efficacy of disease-modifying therapies in multiple sclerosis: a meta-analysis of clinical trialsYinan Zhang, Natalia Gonzalez Caldito, Afsaneh Shirani, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 11, 2020
Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third editionClare Walton, Rachel King, Lindsay Rechtman, et al.
Frontiers in Neurology|June 26, 2023
Processing speed and memory test performance are associated with different brain region volumes in Veterans and others with progressive multiple sclerosisRebecca I Spain, Andrea Hildebrand, Carin S Waslo, et al.
Pageof 2